Drugs / CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06661811 | Nov 2024 → Apr 2028 expected | autoimmune disease | Beijing Boren Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06661811 ↗ |
| Action | Deplete | “CAR-T cells can theoretically completely deplete abnormal antibody-producing B cells” NCT06661811 ↗ |
| Modality | Cell therapy | “CAR-T cell therapy” NCT06661811 ↗ |